SCHEMBL22414751

SCHEMBL22414751

Ic1oc2c3ccccc3c3ccccc3c2c1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 2/20 0.36
▸ CCNB1 P14635 2/20 0.36
▸ GSK3B P49841 2/20 0.36
▸ CDK5 Q00535 2/20 0.36
▸ CDK5R1 Q15078 2/20 0.36
▸ ESR1 P03372 3/20 0.36
▸ ESR2 Q92731 3/20 0.36
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ ACHE P22303 2/20 0.32
▸ LMNA P02545 2/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22414944 0.87 CA1 (0.40) GSK3BESR1ESR2CA1CA2
SCHEMBL22414954 0.87 CA1 (0.40) GSK3BESR1ESR2CA1CA2
SCHEMBL26418906 0.86 TNKS (0.36) MAPTALDH1A1TSHRHPGD
SCHEMBL22414868 0.85 CA1 (0.41) GSK3BESR1ESR2CA1CA2
SCHEMBL22414880 0.85 CA1 (0.41) GSK3BESR1ESR2CA1CA2
SCHEMBL2620727 0.79 TNK2 (0.46) CDK1CCNB1GSK3BCDK5CDK5R1
SCHEMBL16807731 0.77 CA1 (0.40) CDK1CCNB1GSK3BCDK5CDK5R1
SCHEMBL22414661 0.76 ALDH1A1 (0.41) ESR1ESR2ALDH1A1CYP1A2
SCHEMBL22954037 0.75 TNK2 (0.43) CDK1CCNB1GSK3BCDK5CDK5R1
SCHEMBL11545333 0.71 MAOA (0.44) CDK5ESR1ESR2ACHELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLCO2A1 CDK1 2188/4885CCNB1 1966/4885GSK3B 4019/4885
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USE1, SLC16A1, SLCO4C1 CDK1 1430/4885CCNB1 1150/4885GSK3B 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback